Metraipolis › archive › dc_847ff2d18f24

A multimodal biological margin risk index predicts recurrence after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma — Europe PMC PMID:41727460

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41727460
DOI
10.3389/fimmu.2026.1740643
License (as archived)
solo-consultazione
Archived
2026-11-06T01:56:35.223Z
SHA-256 of the archived text
07d5b29aed4afbdfa8dfc6ea1b692786b2265acadbb4fe367bb4c63eab0b6d05
Stable URL of this page
https://metraipolis.com/documento/dc_847ff2d18f24

How to cite

A multimodal biological margin risk index predicts recurrence after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma — Europe PMC PMID:41727460 — Europe PMC (en), https://europepmc.org/article/MED/41727460 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_847ff2d18f24 (Metraipolis archive dc_847ff2d18f24, sha256 07d5b29aed4afbdfa8dfc6ea1b692786b2265acadbb4fe367bb4c63eab0b6d05)
BibTeX
@misc{dc847ff2d18f24,
  title = {A multimodal biological margin risk index predicts recurrence after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma — Europe PMC PMID:41727460},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41727460},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_847ff2d18f24; sha256 07d5b29aed4afbdfa8dfc6ea1b692786b2265acadbb4fe367bb4c63eab0b6d05},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727460. Agents can read the archived copy with the MCP tool read_document.